GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Financials GuangYuYuan Chinese Herbal Medicine Co., Ltd.
Equities
600771
CNE000000MY1
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.69 CNY | +0.35% |
|
+3.34% | -4.82% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 10,188 | 8,344 | 7,308 | 21,077 | 13,618 | 13,211 |
| Enterprise Value (EV) 1 | 10,254 | 8,279 | 7,250 | 21,260 | 13,804 | 13,244 |
| P/E ratio | 27.2 x | 65.2 x | 213 x | -67.3 x | -34.3 x | 150 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 6.29 x | 6.86 x | 6.59 x | 24.7 x | 13.7 x | 10.3 x |
| EV / Revenue | 6.33 x | 6.8 x | 6.54 x | 24.9 x | 13.9 x | 10.3 x |
| EV / EBITDA | 21.2 x | 40.1 x | 156 x | -65.5 x | -39 x | 67.5 x |
| EV / FCF | -17.1 x | 60 x | -7,048 x | -171 x | 91.5 x | 26.4 x |
| FCF Yield | -5.86% | 1.67% | -0.01% | -0.58% | 1.09% | 3.79% |
| Price to Book | 4.45 x | 3.52 x | 3.03 x | 10 x | 8 x | 9.61 x |
| Nbr of stocks (in thousands) | 494,031 | 492,000 | 489,491 | 489,491 | 489,491 | 489,491 |
| Reference price 2 | 20.62 | 16.96 | 14.93 | 43.06 | 27.82 | 26.99 |
| Announcement Date | 19-03-25 | 20-04-29 | 21-04-28 | 22-04-29 | 23-04-21 | 24-04-29 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,619 | 1,217 | 1,109 | 854.2 | 994.7 | 1,284 |
| EBITDA 1 | 484 | 206.5 | 46.58 | -324.5 | -354.1 | 196.2 |
| EBIT 1 | 470.9 | 174.5 | 13.21 | -362.8 | -390.5 | 156.9 |
| Operating Margin | 29.09% | 14.34% | 1.19% | -42.48% | -39.26% | 12.22% |
| Earnings before Tax (EBT) 1 | 452.2 | 158 | 17.51 | -352.6 | -420 | 100.4 |
| Net income 1 | 374.1 | 130.1 | 32 | -316.2 | -398.7 | 90.08 |
| Net margin | 23.11% | 10.69% | 2.88% | -37.02% | -40.09% | 7.02% |
| EPS 2 | 0.7571 | 0.2600 | 0.0700 | -0.6400 | -0.8100 | 0.1800 |
| Free Cash Flow 1 | -600.9 | 137.9 | -1.029 | -124.2 | 150.8 | 502 |
| FCF margin | -37.12% | 11.33% | -0.09% | -14.54% | 15.16% | 39.09% |
| FCF Conversion (EBITDA) | - | 66.77% | - | - | - | 255.9% |
| FCF Conversion (Net income) | - | 106.02% | - | - | - | 557.25% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19-03-25 | 20-04-29 | 21-04-28 | 22-04-29 | 23-04-21 | 24-04-29 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 66.4 | - | - | 183 | 187 | 32.6 |
| Net Cash position 1 | - | 64.9 | 57.9 | - | - | - |
| Leverage (Debt/EBITDA) | 0.1372 x | - | - | -0.5631 x | -0.5268 x | 0.1662 x |
| Free Cash Flow 1 | -601 | 138 | -1.03 | -124 | 151 | 502 |
| ROE (net income / shareholders' equity) | 18.2% | 5.73% | 1.2% | -14.4% | -21.6% | 5.75% |
| ROA (Net income/ Total Assets) | 10.5% | 3.3% | 0.23% | -6.57% | -8.38% | 3.67% |
| Assets 1 | 3,557 | 3,944 | 14,217 | 4,811 | 4,755 | 2,457 |
| Book Value Per Share 2 | 4.630 | 4.820 | 4.930 | 4.290 | 3.480 | 2.810 |
| Cash Flow per Share 2 | 0.2500 | 0.4900 | 0.8000 | 0.3000 | 0.5000 | 0.4900 |
| Capex 1 | 200 | 87.4 | 49.6 | 18.2 | 8.67 | 2.51 |
| Capex / Sales | 12.38% | 7.18% | 4.48% | 2.13% | 0.87% | 0.2% |
| Announcement Date | 19-03-25 | 20-04-29 | 21-04-28 | 22-04-29 | 23-04-21 | 24-04-29 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.82% | 1.74B | |
| +39.33% | 6.11B | |
| -18.38% | 4.35B | |
| -9.17% | 3.19B | |
| +3.98% | 3.15B | |
| -3.41% | 2.51B | |
| +48.74% | 1.98B | |
| -1.24% | 1.63B | |
| -8.96% | 1.6B | |
| +39.87% | 1.45B |
- Stock Market
- Equities
- 600771 Stock
- Financials GuangYuYuan Chinese Herbal Medicine Co., Ltd.
